Free Trial
NYSE:WST

West Pharmaceutical Services Q3 2026 Earnings Date & Estimates

West Pharmaceutical Services logo
$366.08 +2.81 (+0.77%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$361.56 -4.52 (-1.23%)
As of 10/9/2026 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

West Pharmaceutical Services is scheduled to report Q3 2026 earnings on Thursday, October 29, 2026, before market opens. The conference call is scheduled for 8:00 AM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:00 AM ET

What Analysts Expect from West Pharmaceutical Services in Q3 2026

West Pharmaceutical Services is expected to post earnings of $2.20 per share on revenue of $826.77 million. In the same quarter a year earlier West Pharmaceutical Services reported $1.96 per share on revenue of $804.60 million. West Pharmaceutical Services last reported on July 23, 2026, posting $2.37 per share and beating the $2.08 consensus estimate. West Pharmaceutical Services has beaten the consensus EPS estimate in 8 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$2.20
Expected Revenue
$826.77 million
Prior-Year EPS
$1.96
Prior-Year Revenue
$804.60 million
Expected EPS Growth
+12.2%
Expected Revenue Growth
+2.8%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$2.37 (Beat by +$0.29)
Last Quarter Revenue
$872.30 million
EPS Beat Rate
8 of last 8 quarters

West Pharmaceutical Services Q3 2026 Earnings FAQ

West Pharmaceutical Services (NYSE:WST) is scheduled to report Q3 2026 earnings on Thursday, October 29, 2026, before market opens.

West Pharmaceutical Services' Q3 2026 earnings conference call is scheduled for Thursday, October 29, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect West Pharmaceutical Services to post earnings of $2.20 per share for Q3 2026.

The consensus revenue estimate for West Pharmaceutical Services is $826.77 million for Q3 2026.

West Pharmaceutical Services Earnings Headlines

West to Host Third-Quarter 2026 Conference Call
First Look: Elon’s “Starphone”
Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.tc pixel
West Pharma: Still A Buy, But Expectations Are Rising
See More West Pharmaceutical Services Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like West Pharmaceutical Services? Sign up for Earnings360's daily newsletter to receive timely earnings updates on West Pharmaceutical Services and other key companies, straight to your email.

About West Pharmaceutical Services

West Pharmaceutical Services (NYSE:WST) is a global manufacturer of components and systems used in the packaging and delivery of injectable drugs and other healthcare products. The company serves pharmaceutical, biotechnology and medical device manufacturers.

Its products include elastomer closures, syringe and cartridge components, vial seals, administration systems, drug-delivery components and other specialized packaging solutions. West also provides contract-manufacturing services for certain medical and pharmaceutical products.

Founded in 1923, West Pharmaceutical Services supplies customers through manufacturing and operations in North America, Europe and Asia. Its offerings are designed to support the safety, compatibility and reliable delivery of injectable and other pharmaceutical products.

View West Pharmaceutical Services Profile